HCA Healthcare price target lowered to $525 from $588 at Cantor Fitzgerald
Cantor Fitzgerald lowered the firm's price target on HCA Healthcare to $525 from $588 and keeps an Overweight rating on the shares. Cantor prefers payors over providers heading into Q2 earnings, supported by management discussions, proprietary checks, and investor conversations, the analyst tells investors in a research note. Payors appear better positioned with continued strength in government insurance lines and VBC opportunities, while provider commentary may struggle to meet elevated expectations, limiting upside despite potential guidance increases, the firm says.
Cantor Fitzgerald lowered the firm's price target on HCA Healthcare to $525 from $588 and keeps an Overweight rating on the shares.
Cantor prefers payors over providers heading into Q2 earnings, supported by management discussions, proprietary checks, and investor conversations, the analyst tells investors in a research note.
Payors appear better positioned with continued strength in government insurance lines and VBC opportunities, while provider commentary may struggle to meet elevated expectations, limiting upside despite potential guidance increases, the firm says.